BeOne Medicines Ltd
253 hedge funds and large institutions have $19.5B invested in BeOne Medicines Ltd in 2021 Q1 according to their latest regulatory filings, with 40 funds opening new positions, 93 increasing their positions, 87 reducing their positions, and 34 closing their positions.
39% more capital invested
Capital invested by funds: $14.1B → $19.5B (+$5.46B)
18% more first-time investments, than exits
New positions opened: 40 | Existing positions closed: 34
2% more funds holding
Funds holding: 248 → 253 (+5)
7% more repeat investments, than reductions
Existing positions increased: 93 | Existing positions reduced: 87
0.11% more ownership
Funds ownership: 4.63% → 4.74% (+0.11%)
8% less funds holding in top 10
Funds holding in top 10: 13 → 12 (-1)
73% less call options, than puts
Call options by funds: $24.8M | Put options by funds: $91.1M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
+$553M |
| 2 |
Primecap Management
Pasadena,
California
|
+$173M |
| 3 |
Capital International Investors
Los Angeles,
California
|
+$142M |
| 4 |
California Public Employees Retirement System
Sacramento,
California
|
+$68.1M |
| 5 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
+$59.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Boxer Capital
San Diego,
California
|
-$116M |
| 2 |
Sands Capital Management
Arlington,
Virginia
|
-$108M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$94.7M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$82.3M |
| 5 |
AG
Artal Group
Luxembourg
|
-$49.7M |
ONC Hedge Fund Activity: Q1 2021 in Review
253 of the 5,711 institutional investors tracked by Wall St. Rank reported a position in BeOne Medicines Ltd (ONC) for Q1 2021, worth a combined $19.5B — up 39% from $14.1B a quarter earlier.
Buyers outnumbered sellers: 40 funds opened new ONC positions and 34 closed out — a net gain of 6 holders — while 93 added to existing stakes and 87 trimmed.
The largest buyer was Invesco, adding an estimated $553M. The largest seller was Boxer Capital, cutting an estimated $116M.
- 253 institutional investors held BeOne Medicines Ltd (ONC) as of Q1 2021, up from 248 in Q4 2020.
- Funds reported $19.5B of BeOne Medicines Ltd stock for Q1 2021, up 39% quarter-over-quarter.
- 40 funds opened new BeOne Medicines Ltd positions in Q1 2021 and 34 closed out, a net change of +6 holders.
- The largest BeOne Medicines Ltd buyer in Q1 2021 was Invesco, an estimated $553M added.
- The largest BeOne Medicines Ltd seller in Q1 2021 was Boxer Capital, an estimated $116M sold.
Based on aggregated 13F filings for Q1 2021.